Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

News releases from Fluidigm Corporation

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
FDA Grants Emergency Use Authorization for Home Collection Kit for Advanta Dx SARS-CoV-2 RT-PCR Assay
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Announces Fourth Quarter and Full Year 2020 Financial Results
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Announces Collaboration with Zhejiang PuLuoTing Health Technology Co. Ltd to Market Fluidigm CyTOF Technology to Clinical Labs in China
PLT and Fluidigm Collaborate on Submission to the National Medical Products Administration for a CyTOF Device Approved for Diagnostic Use in China 
Tickers FLDM
From GlobeNewswire News Releases
George Mason University Providing COVID-19 Testing with Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay on Biomark HD Platform
Tickers FLDM
From GlobeNewswire News Releases
NIH Sponsored Study at Stanford University School of Medicine to Utilize Fluidigm Mass Cytometry Technology and Maxpar Direct Immune Profiling Assay to Evaluate Immune Responses in Pediatric Patients
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
Tickers FLDM
From GlobeNewswire News Releases
Helix Specialty Diagnostics Partners with Genomic LTC DX to Provide COVID-19 Testing with Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay on Biomark HD Platform
Major Midwest Labs Targeting 3,000 Tests per Day 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Receives CE-IVD Mark for Its Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay for COVID-19
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Announces Conference Call and Webcast of Fourth Quarter and Full Year 2020 Financial Results
Tickers FLDM
From GlobeNewswire News Releases
New Data Published in Gastroenterology Demonstrate the Power of Fluidigm’s Imaging Mass Cytometry on the Hyperion Imaging System to Identify Novel Targets for Pancreatic Cancer Therapy
Tickers FLDM
From GlobeNewswire News Releases
Dr. Ana K. Stankovic, MD, PhD, Appointed to Fluidigm Board of Directors
Tickers FLDM
From GlobeNewswire News Releases
Key Regulatory Body in India Grants Commercial License for Fluidigm Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay
Fluidigm Assay is Among First Saliva-Based COVID-19 Tests Licensed for Use by Designated Labs in India 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm to Participate at the Piper Sandler 32nd Annual Virtual Healthcare Conference
Tickers FLDM
From GlobeNewswire News Releases
Study Utilizing Imaging Mass Cytometry Details Changes in Lung Tissue Architecture at the Single-Cell Level in Patients with COVID-19
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm COVID-19 Community Connect Program Builds a Network of Testing Partners to Increase Access of Saliva-Based SARS-CoV-2 Testing for Communities
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm to Present at Upcoming Health Care Investor Conference
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Announces Third Quarter 2020 Financial Results
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm and Healthvana Partner to Offer COVID-19 Test Results Delivery through Innovative Digital Platform
Patients Receive Results, Education and Next Steps on Their Mobile Phones to Prevent Further Spread of the Disease 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Mass Cytometry Technologies, Including CyTOF, Imaging Mass Cytometry and Maxpar Direct, Utilized in More than 100 National Clinical Trials
25 Trials Utilizing Mass Cytometry Initiated in 2020 
Tickers FLDM
From GlobeNewswire News Releases
Dante Labs Launching COVID-19 Testing in Europe Utilizing Fluidigm Pathogen Detection Kit on Biomark HD Platform
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm to Offer Millions of Advanta COVID-19 Tests at Low Cost to U.S. Colleges and Universities
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Announces Conference Call and Webcast of Third Quarter 2020 Financial Results
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Joins Global Consortium of Cancer Prevention Experts
Tickers FLDM
From GlobeNewswire News Releases
ImmunoGenomics and Vero Diagnostics Providing COVID-19 Testing with Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay on Biomark HD Platform
Regional CLIA-Certified Labs among Growing Number of Customers Expanding SARS-CoV-2 Testing with Fluidigm Technology 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Announces Agenda for 9th Annual Mass Cytometry Summit
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Achieves Initial Milestone under NIH Rapid Acceleration of Diagnostics Agreement
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm to Participate at the 2020 Cantor Virtual Global Healthcare Conference
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Granted FDA Emergency Use Authorization for Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay for COVID-19
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Announces Second Quarter 2020 Financial Results
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm and De Novo Software to Offer Mass Cytometry Customers a Streamlined Solution for Data Analysis
License for De Novo Software’s FCS Express 7 Flow to be Provided to Customers Purchasing Fluidigm Helios and Hyperion Imaging Systems 
Tickers FLDM
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.